AstraZeneca
By Maggie Fick and Yadarisa Shabong (Reuters) -Drugmaker AstraZeneca (NASDAQ:) lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong demand for its cancer and rare diseases medicines, after third-quarter results beat estimates. The London-listed company doubled down on plans for U.S.…
Investing.com – European stock markets slipped lower Tuesday, as the positive momentum at the start of the week stalled amid concerns of U.S. interest rates staying higher for longer than expected. At 03:10 ET (07:10 GMT), the in Germany traded 0.1% lower, the in France fell 0.4%, while the in…
